Charles River Laboratories International Balance Sheet
NYSE: CRLHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Charles River Laboratories International financial position
At the end of fiscal 2025, Charles River Laboratories International reported total assets of $7.14 billion, down 5.2% from a year earlier against total liabilities of $3.92 billion. Shareholders' equity stood at $3.16 billion, or 44.4% of assets. The company held $213.8 million in cash and equivalents against $2.14 billion of debt, a net debt position of $1.92 billion.
The current ratio (current assets divided by current liabilities) was 1.29, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.68.
Summary generated from market data by MetaCap's automated system. Methodology
Charles River Laboratories International balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-27 | FY 20242024-12-28 | FY 20232023-12-30 | FY 20222022-12-31 | FY 20212021-12-25 | FY 20202020-12-26 | FY 20192019-12-28 | FY 20182018-12-29 | FY 20172017-12-30 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 213.77M | 194.61M | 276.77M | 233.91M | 241.21M | 228.42M | 238.01M | 195.44M | 163.79M | 117.63M |
| Short-Term Investments | — | — | — | — | 1.06M | 1.02M | 941.00K | 885.00K | 28.49M | 3.77M |
| Receivables | 708.86M | 720.91M | 780.38M | 752.39M | 642.88M | 617.74M | 514.03M | 472.25M | 430.02M | 364.05M |
| Inventory | 299.10M | 278.54M | 380.26M | 255.81M | 199.15M | 185.69M | 160.66M | 127.89M | 114.96M | 95.83M |
| Total Current Assets | 1.45B | 1.40B | 1.61B | 1.44B | 1.27B | 1.20B | 1.02B | 897.84M | 826.63M | 656.83M |
| Property, Plant & Equipment | 1.66B | 1.60B | 1.64B | 1.47B | 1.29B | 1.12B | 1.04B | 932.88M | 781.97M | 755.83M |
| Goodwill | 2.76B | 2.85B | 3.10B | 2.85B | 2.71B | 1.81B | 1.54B | 1.25B | 804.91M | 787.52M |
| Intangible Assets | 340.00M | 723.40M | 864.05M | 955.27M | 1.06B | 787.60M | 689.41M | 610.89M | 369.76M | 394.45M |
| Total Assets | 7.14B | 7.53B | 8.20B | 7.60B | 7.02B | 5.49B | 4.69B | 3.86B | 2.93B | 2.71B |
| Accounts Payable | 148.80M | 140.34M | 168.94M | 205.91M | 198.13M | 122.47M | 111.50M | 66.25M | 77.84M | 68.48M |
| Short-Term Debt | 166.00K | 155.00K | 3.17M | 1.35M | 101.00K | 47.20M | 35.55M | 28.23M | 28.55M | 24.56M |
| Total Current Liabilities | 1.12B | 994.10M | 1.06B | 1.09B | 1.03B | 839.75M | 710.18M | 558.22M | 463.50M | 429.59M |
| Long-Term Debt | 2.14B | 2.24B | 2.65B | 2.71B | 2.66B | 1.93B | 1.85B | 1.63B | 1.09B | 1.19B |
| Total Liabilities | 3.92B | 4.02B | 4.54B | 4.58B | 4.43B | 3.35B | 3.03B | 2.52B | 1.87B | 1.86B |
| Shareholders' Equity | 3.16B | 3.46B | 3.60B | 2.98B | 2.53B | 2.11B | 1.63B | 1.32B | 1.05B | 836.77M |
| Retained Earnings | 1.39B | 1.81B | 1.89B | 1.43B | 980.75M | 625.41M | 280.33M | 42.10M | 288.66M | 165.30M |
| Total Debt | 2.14B | 2.24B | 2.65B | 2.71B | 2.66B | 1.98B | 1.89B | 1.65B | 1.12B | 1.21B |
| Net Cash (Debt) | -1.92B | -2.05B | -2.37B | -2.47B | -2.42B | -1.75B | -1.65B | -1.46B | -928.26M | -1.09B |
| Shares Outstanding | 49.22M | 51.14M | 51.34M | 50.94M | 50.48M | 49.77M | 48.94M | 48.21M | 47.40M | 47.36M |
This table shows 10 annual periods of Charles River Laboratories International's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CRL's reporting calendar. What is a balance sheet?